Not all patients pursue prostate biopsy after abnormal prostate specific antigen results

Urologic Oncology

Volumn 2, Issue 1, 1996, Pages 35-39

  Krongrad, Arnon ^a,b   Kim Jr , Charles O ^a   Burke, Michael A ^a   Granville, Lisa J ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

diagnosis; DRE; early detection; prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER RISK; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECTUM; REPRODUCIBILITY;

EID: 0029784940     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/1078-1439(96)00038-5     Document Type: Article

References (8)

1. 1. Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol 1991;165:658-62.
2. 2. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vesella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992;147:841-5.
3. 3. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol 1994;151:1283-90.
4. 4. Bennett CL, Greenfield S, Aronow H, Ganz P, Vogelzang NJ, Elashoff RM. Patterns of care related to age of men with prostate cancer. Cancer 1991;67:2633-41.
5. 5. Greenfield S, Giovanni A, McNeil BJ, Cleary BD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Med Care 1993;257:141-54.
6. 6. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-31.
7. 7. Shaheen JA, Amin M, Harty JI. Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist. Urol 1993;42:533-5.
8. 8. Gustafsson O, Theorell T, Norming U, Prski A, Ohmstrom M, Nyman CR. Psychological reactions in men screened for prostate cancer. Br J Urol 1995;75:631-6.